Last update 22 Mar 2025

Teneligliptin Hydrobromide Hydrate/Metformin Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Metformin/MP-513, Metformin/teneligliptin, MP-513/metformin
+ [3]
Target
DPP-4 x PRKAB1
Action
inhibitors, activators
Mechanism
DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors), PRKAB1 activators(Protein kinase AMP-activated non-catalytic subunit beta 1 activators)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
Diabetes Mellitus, Type 2
Inactive Indication-
Originator Organization
Handok, Inc.Handok, Inc.
Active Organization
Handok, Inc.Handok, Inc.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
South Korea (31 Mar 2015),
Diabetes Mellitus, Type 2
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC4H12ClN5
InChIKeyOETHQSJEHLVLGH-UHFFFAOYSA-N
CAS Registry1115-70-4
View All Structures (2)

Related

1
Clinical Trials associated with Teneligliptin Hydrobromide Hydrate/Metformin Hydrochloride
NCT03787017
/ CompletedPhase 1
A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of FDC of MP-513 20mg and Metformin XR 1000mg With Coadministration of the Two Separate Drugs in Healthy Male Volunteers
100 Clinical Results associated with Teneligliptin Hydrobromide Hydrate/Metformin Hydrochloride
Login to view more data
100 Translational Medicine associated with Teneligliptin Hydrobromide Hydrate/Metformin Hydrochloride
Login to view more data
100 Patents (Medical) associated with Teneligliptin Hydrobromide Hydrate/Metformin Hydrochloride
Login to view more data
100 Deals associated with Teneligliptin Hydrobromide Hydrate/Metformin Hydrochloride
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
A10BD
-

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2
South Korea
Handok, Inc.Handok, Inc.
31 Mar 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free